Menopausal Hot Flashes - Pipeline Review, H2 2013

Market: Pharmaceuticals and Healthcare

Global, 51 pages report, published by Global Markets Direct

Keywords : Menopausal Hot Flashes Therapeutic Products under Development, Key Players in Menopausal Hot Flashes Therapeutics, Menopausal Hot Flashes Pipeline Overview, Menopausal Hot Flashes Pipeline, Menopausal Hot Flashes Pipeline Assessment

Report ThumbnailSeptember-2013
Menopausal Hot Flashes - Pipeline Review, H2 2013

Summary

Global Markets Direct’s, 'Menopausal Hot Flashes - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Menopausal Hot Flashes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Menopausal Hot Flashes. Menopausal Hot Flashes - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Menopausal Hot Flashes.
- A review of the Menopausal Hot Flashes products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Menopausal Hot Flashes pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Menopausal Hot Flashes.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Menopausal Hot Flashes pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
  • List of Figures
  • Number of Products under Development for Menopausal Hot Flashes, H2 2013 7
  • Products under Development for Menopausal Hot Flashes - Comparative Analysis, H2 2013 8
  • Products under Development by Companies, H2 2013 9
  • Late Stage Products, H2 2013 10
  • Mid Clinical Stage Products, H2 2013 11
  • Early Clinical Stage Products, H2 2013 12
  • Pre-Clinical Stage Products, H2 2013 13
  • Assessment by Monotherapy Products, H2 2013 21
  • Assessment by Route of Administration, H2 2013 22
  • Assessment by Stage and Route of Administration, H2 2013 23
  • Assessment by Molecule Type, H2 2013 24
  • Assessment by Stage and Molecule Type, H2 2013 25
  • List of Tables
  • Number of Products Under Development for Menopausal Hot Flashes, H2 2013 7
  • Products under Development for Menopausal Hot Flashes - Comparative Analysis, H2 2013 8
  • Number of Products under Development by Companies, H2 2013 9
  • Comparative Analysis by Late Stage Development, H2 2013 10
  • Comparative Analysis by Mid Clinical Stage Development, H2 2013 11
  • Comparative Analysis by Early Clinical Stage Development, H2 2013 12
  • Comparative Analysis by Pre-Clinical Stage Development, H2 2013 13
  • Products under Development by Companies, H2 2013 14
  • Eisai Co., Ltd., H2 2013 15
  • Bionovo, Inc., H2 2013 16
  • Concert Pharmaceuticals, Inc., H2 2013 17
  • PharmaNova Inc., H2 2013 18
  • Intra-Cellular Therapies, Inc., H2 2013 19
  • Pherin Pharmaceuticals, Inc., H2 2013 20
  • Assessment by Monotherapy Products, H2 2013 21
  • Assessment by Stage and Route of Administration, H2 2013 23
  • Assessment by Stage and Molecule Type, H2 2013 25
  • Menopausal Hot Flashes Therapeutics - Drug Profile Updates 36
  • Menopausal Hot Flashes Therapeutics - Discontinued Products 42
  • Menopausal Hot Flashes Therapeutics - Dormant Products 43
  • Table of Contents
  • Table of Contents 2
  • List of Tables 4
  • List of Figures 4
  • Introduction 5
  • Global Markets Direct Report Coverage 5
  • Menopausal Hot Flashes Overview 6
  • Therapeutics Development 7
  • An Overview of Pipeline Products for Menopausal Hot Flashes 7
  • Menopausal Hot Flashes Therapeutics under Development by Companies 9
  • Late Stage Products 10
  • Comparative Analysis 10
  • Mid Clinical Stage Products 11
  • Comparative Analysis 11
  • Early Clinical Stage Products 12
  • Comparative Analysis 12
  • Pre-Clinical Stage Products 13
  • Comparative Analysis 13
  • Menopausal Hot Flashes Therapeutics - Products under Development by Companies 14
  • Companies Involved in Menopausal Hot Flashes Therapeutics Development 15
  • Eisai Co., Ltd. 15
  • Bionovo, Inc. 16
  • Concert Pharmaceuticals, Inc. 17
  • PharmaNova Inc. 18
  • Intra-Cellular Therapies, Inc. 19
  • Pherin Pharmaceuticals, Inc. 20
  • Menopausal Hot Flashes - Therapeutics Assessment 21
  • Assessment by Monotherapy Products 21
  • Assessment by Route of Administration 22
  • Assessment by Molecule Type 24
  • Drug Profiles 26
  • gabapentin ER - Drug Profile 26
  • Product Description 26
  • Mechanism of Action 26
  • R&D Progress 26
  • RAD-1901 - Drug Profile 28
  • Product Description 28
  • Mechanism of Action 28
  • R&D Progress 28
  • MF-101 - Drug Profile 30
  • Product Description 30
  • Mechanism of Action 30
  • R&D Progress 30
  • CTP-347 - Drug Profile 32
  • Product Description 32
  • Mechanism of Action 32
  • R&D Progress 32
  • PH-80-HF - Drug Profile 34
  • Product Description 34
  • Mechanism of Action 34
  • R&D Progress 34
  • Women's Health Program - Drug Profile 35
  • Product Description 35
  • Mechanism of Action 35
  • R&D Progress 35
  • Menopausal Hot Flashes Therapeutics - Drug Profile Updates 36
  • Menopausal Hot Flashes Therapeutics - Discontinued Products 42
  • Menopausal Hot Flashes Therapeutics - Dormant Products 43
  • Menopausal Hot Flashes - Product Development Milestones 44
  • Featured News & Press Releases 44
  • Oct 15, 2012: Depomed Announces Serada NDA Acceptance And FDA Advisory Committee Meeting 44
  • Oct 03, 2012: Depomed Announces Presentation Of Phase III Trial Data Of Serada At 2012 North American Menopause Society Annual Meeting 44
  • Sep 26, 2012: Eaton Scientific Highlights International Potential For Tropine 3 As Globally Accepted Non-Hormonal Treatment For Hot Flash Symptoms 46
  • Sep 25, 2012: Eaton Scientific Provides Outline On Market Potential Of Tropine 3 For Non-Hormonal Treatment Of Hot Flashes 47
  • Sep 13, 2012: Eaton Scientific Teams Up With Urologist Dr Jennifer Berman To Advance Tropine 3 Trials And Marketing 47
  • Sep 06, 2012: Eaton Scientific Completes Study Protocol For Phase I/II Study Of Tropine 3 For Treatment Of Hot Flashes 47
  • Sep 04, 2012: Eaton Scientific Enters Agreement With RoxSan Pharmacy To Provide Tropine 3 For Upcoming Clinical Trial Participants 48
  • Aug 28, 2012: Eaton Scientific Announces Clinical Trial Plans For Tropine 3 For Treatment Of Hot Flashes In Menopausal Women 48
  • Jul 31, 2012: Depomed Announces Submission Of Serada New Drug Application 49
  • Apr 17, 2012: Depomed Intends To File NDA For Serada For Treatment Of Menopausal Hot Flashes 49
  • Appendix 50
  • Methodology 50
  • Coverage 50
  • Secondary Research 50
  • Primary Research 50
  • Expert Panel Validation 50
  • Contact Us 51
  • Disclaimer 51

Please select a license type

Share

Related Products

Global Markets DirectMenopausal Hot Flashes - Pipeline Review, H2 2013Product ThumbnailMenopausal Hot Flashes - Pipeline Review, H2 2013, Industry ReportProduct #: 113356
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved